Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec:99:177-183.
doi: 10.1016/j.neuro.2023.10.008. Epub 2023 Oct 17.

KEAP1 polymorphisms and neurodevelopmental outcomes in children with exposure to prenatal MeHg from the Seychelles Child Development Study Nutrition Cohort 2

Affiliations

KEAP1 polymorphisms and neurodevelopmental outcomes in children with exposure to prenatal MeHg from the Seychelles Child Development Study Nutrition Cohort 2

Helena Korres de Paula et al. Neurotoxicology. 2023 Dec.

Abstract

Background: Humans differ in the metabolism of the neurotoxicant methyl mercury (MeHg). This variation may be partially due to variation in genes encoding the transcription factor Nuclear factor E2-related factor 2 (NRF2) and its negative regulator Kelch-like ECH-Associated Protein 1 (KEAP1), which regulate glutathione and related transporter and antioxidant proteins that play a role in the metabolism and neurotoxicity of MeHg.

Aim: To elucidate a potential risk from genetic variation in NFE2L2 (encoding NRF2) and KEAP1 toward prenatal mercury exposure and child neurodevelopmental outcomes at 20 months and 7 years of age in a population with variable prenatal exposure to MeHg from maternal fish consumption.

Material and methods: Nutrition Cohort 2 is a mother-child cohort in the Republic of Seychelles. Children were genotyped for NFE2L2 (rs2364723, rs13001694) and KEAP1 (rs8113472, rs9676881) polymorphisms (N = 1285 after removing siblings). Total mercury (Hg) was measured in cord blood as a biomarker for prenatal MeHg exposure. Child neurodevelopmental outcomes included the Bayley Scales of Infant Development II administered at 20 months of age, and outcomes across multiple neurodevelopmental domains from 14 tests administered in children and 3 instruments completed by parents when children were 7 years of age.

Results: The mean cord blood MeHg concentration was 34 (95% CI 11, 75) µg/L. None of the four polymorphisms had a significant association (p < 0.05) with either cord MeHg or neurodevelopmental test results at 20 months. There were no significant associations between either NFE2L2 polymorphism and any developmental test scores. At 7 years, children carrying KEAP1 rs8113472 CA showed significantly worse performance on psychomotor function than children with the CC variant (finger tapping, dominant hand: β - 1.19, SE 0.34; finger tapping, non-dominant hand: β - 0.92, SE 0.31) and worse social communication (SCQ Total: β 0.65, SE 0.27). Children carrying rs8113472 AA, versus children with CC, showed significantly better performance on social communication (SRS Total: β - 8.88, SE 3.60). Children carrying KEAP1 rs9676881 AG, versus children with GG, showed significantly worse performance on psychomotor function (trailmaking A time: β 8.66, SE 3.37) and cognition (KBIT Matrices: β - 0.96, SE 0.36).

Conclusion: No associations between NFE2L2 and KEAP1 polymorphisms and MeHg concentration were identified. However, at 7 years, KEAP1 polymorphisms were associated with differences in neurodevelopmental outcomes in children from a population with high fish intake.

Keywords: Child neurodevelopment; Cord mercury; KEAP1; NFE2L2; NRF2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Tanzy M. Love, Gene E. Watson, Sally W. Thurston, Alison J. Yeates, Maria S. Mulhern, Emeir M. McSorley, J.J. Strain, Conrad F. Shamlaye, G.J. Myers, Matthew D. Rand, and Edwin van Wijngaarden report financial support was provided by the National Institutes of Health. Helena Korres de Paulaa, Tanzy M. Love, Daniela Pineda, Gene E. Watson, Alison J. Yeates and, Karin Broberg report financial support was provided by The Swedish Research Council for Health, Working Life and Welfare (FORTE), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), and the Karolinska Institutet. Conrad Shamlaye reports in kind support from the Government of Seychelles.

References

    1. Cernichiari E, Brewer R, Myers GM, Marsh DO, Lapham LW, Cox C, Shamlaye CF, Berlin M, Davidson PW, Clarkson TW (1995) Monitoring methylmercury during pregnancy: maternal hair predicts fetal brain exposure. Neurotoxicology 16(4):705–710. - PubMed
    1. Clarkson TW, Magos L, Myers GJ (2003) The Toxicology of Mercury — Current Exposures and Clinical Manifestations. The New England Journal of Medicine, 349, 1731–7. - PubMed
    1. Costa LG, Aschner M, Vitalone A, Syversen T, Soldin OP (2004) Developmental neuropathology of environmental agents. Annual Review of Pharmacology and Toxicology, 44, 87–110. - PMC - PubMed
    1. Culbreth M, Zhang Z, Aschner M (2017) Methylmercury augments Nrf2 activity by downregulation of the Src family kinase Fyn. Neurotox. 62:200–206. - PMC - PubMed
    1. Daniels JL, Longnecker MP, Rowland AS, Golding J, The ALSPAC Study Team-University of Bristol Institute of Child Health (2004) Fish intake during pregnancy and early cognitive development of offspring. Epidemiology, 15, 394–402. - PubMed

Publication types